SMAD2 and ovarian carcinoma: Smad2/Smad3 represent direct targets of TGF-β receptor kinase 1 and mediate transcriptional regulation through their intrinsic ability to bind to DNA; their phosphorylation plays a crucial role in the pathogenesis of ovarian cancer [30].